US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. June 14, 2019

    'Negotiation Class' May Tee Up Sweeping Deal In Opioid MDL

    Local governments in the multidistrict opioid litigation on Friday launched an unusual effort to create a "negotiation class" of cities and counties that would seek a global settlement with drug companies accused of igniting a nationwide firestorm of addiction.

  2. June 12, 2019

    Shoshone Tribe Joins Opioid MDL, Details Epidemic's Impact

    The Eastern Shoshone Tribe announced on Tuesday that it is joining a national multidistrict litigation seeking to hold pharmaceutical companies responsible for the country's opioid epidemic, alleging that the drugs have hit Native American nations particularly hard.

  3. May 08, 2019

    BakerHostetler Fights 'Indefensible' DQ In Opioid MDL

    BakerHostetler on Wednesday asked the Sixth Circuit to vacate an Ohio judge's decision to disqualify the firm from representing Endo Pharmaceuticals in two bellwether cases in the multidistrict opioid litigation, saying the decision will affect the entire MDL.

  4. April 26, 2019

    Atty Sanctions Axed In Opioid MDL, Allowing Doc's Testimony

    An Ohio federal judge on Friday scrapped attorney sanctions that would have barred testimony from a high-profile pain doctor in the multidistrict opioid litigation, calling the discipline "too extreme" despite a galling failure by plaintiffs' attorneys to divulge a deal with the doctor.

  5. April 25, 2019

    Opioid MDL Attys' Concealment Merited Sanction: Drug Cos.

    Plaintiffs' attorneys who hid key witness testimony in the multidistrict opioid litigation were properly sanctioned by having that testimony blocked from a bellwether trial, drug companies told an Ohio federal court on Thursday.

  6. April 18, 2019

    Postpone Opioid MDL Trial? Get Real, Judge Says

    An Ohio federal judge on Thursday said that drug companies in the multidistrict opioid litigation are apparently maneuvering to indefinitely delay a bellwether trial and that the idea isn't even worthy of consideration.

  7. April 16, 2019

    Opioid MDL Attys Say Sanction 'Does Not Fit The Crime'

    Plaintiffs attorneys in the multidistrict opioid litigation are contesting a sanction that would block testimony from an influential doctor whose cooperation they failed to disclose, calling it "a punishment that does not fit the crime."

  8. April 10, 2019

    No More Trial Delays In Opioid MDL, Judge Says

    An Ohio federal judge on Wednesday declared that a highly anticipated bellwether trial in the multidistrict opioid litigation won't be postponed again, a move that follows delays and allegations that the drug companies are stalling.

  9. April 08, 2019

    Opioid MDL Attys Sanctioned For Hiding Doctor's Cooperation

    Plaintiffs attorneys in the multidistrict opioid litigation misled drug company defendants about the cooperation of an influential doctor who has long advised drug companies and can no longer use his testimony at a bellwether trial, according to a newly released Ohio federal court ruling.

  10. April 08, 2019

    BakerHostetler Can't Overturn Opioid MDL Disqualification

    BakerHostetler will remain disqualified from representing Endo Pharmaceuticals in two bellwether cases in the multidistrict opioid litigation, an Ohio federal judge ruled Monday, saying the drugmaker waited too long to cry foul.